RTORentokil Initial plc
The schedule
- Thu15Oct
Ongoing regulatory shifts by the EPA and European agencies regarding rodenticides and biocides present persistent operational hurdles for the pest control industry.
- Mon15Mar
Given the $6.1B debt load on the balance sheet stemming from the Terminix acquisition, management's capital allocation update will clarify the path to deleveraging.
- Thu29Apr
Q3 results will focus heavily on organic revenue growth in the core pest control segment to justify the current 24.4x P/E multiple against an industry average of 20.6x.
- Thu29Jul
Q4 and full-year results provide the ultimate scorecard on whether Rentokil successfully captured the projected cost synergies from Terminix and stabilized its North American market share.
- Thu28Oct
Past
- Wed30Sep
Rentokil's integration of Terminix remains the critical driver of its North American margin expansion. With shares trading near 52-week lows, this investor presentation is pivotal for management to reaffirm expected synergy targets.
- Thu30Jul
Actual outcome: Bear
Rentokil reported in-line EPS of $0.55, but shares plunged after the company warned of weaker residential demand in North America and abandoned a key margin target. Despite higher first-half revenue and profit, the softening of customer leads and the dropped margin target overshadowed the results, driving the stock well below the bear floor.
Q2 2026 results evaluating margin defense against industrial operating cost pressures.
- Thu30Jul
Actual outcome: Bear · $23.59 at outcome
Rentokil's Q2 2026 earnings report revealed weaker-than-expected North American demand, leading to a 17% plunge. The company abandoned a key margin target and warned of softened residential customer leads, triggering sharp sell-off despite beating adjusted profit estimates. The negative guidance overshadowed mixed results. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: -23.1% from 2026-07-17 to 2026-08-06 (~3.3σ vs typical 10d vol). Target date 2026-08-06 reached; move through 2026-08-06 observed. Confidence 95%. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-12: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-12 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-13: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-13 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-14: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-14 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-17: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-17 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-18: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-18 observed.
Rentokil's Q2 2026 earnings report revealed weaker-than-expected North American demand, leading to a 17% plunge. The company abandoned a key margin target and warned of softened residential customer leads, triggering sharp sell-off despite beating adjusted profit estimates. The negative guidance overshadowed mixed results. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: -23.1% from 2026-07-17 to 2026-08-06 (~3.3σ vs typical 10d vol). Target date 2026-08-06 reached; move through 2026-08-06 observed. Confidence 95%. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-06: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-06 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-07: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-07 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-12: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-12 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-13: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-13 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-14: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-14 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-17: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-17 observed. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-08-18: -23.1% from 2026-07-17 (~3.3σ). Target date 2026-08-06 reached; move through 2026-08-18 observed.
- Wed24Jun
Actual outcome: Bear · $29.02 at outcome
Rentokil (RTO) reported Q1 earnings with an EPS of $0.55, exactly matching analyst estimates. Despite the company's announcement of new digital advancements to enhance its pest control customer experience, the lack of an earnings beat or stronger forward catalysts disappointed investors. This drove a bearish reaction, keeping the stock well below the $31.62 bear floor.
Rentokil (RTO) reported Q1 earnings with an EPS of $0.55, exactly matching analyst estimates. Despite the company's announcement of new digital advancements to enhance its pest control customer experience, the lack of an earnings beat or stronger forward catalysts disappointed investors. This drove a bearish reaction, keeping the stock well below the $31.62 bear floor.
